Literature DB >> 7685967

Antigenic sites on type 2 poliovirus.

V Patel1, M Ferguson, P D Minor.   

Abstract

Monoclonal escape variants isolated from the Sabin strain of type 2 poliovirus were examined. Mutations were identified in regions known to be antigenic in other serotypes, although the extent to which they were linked by common antibodies varied. One complex site involved regions of VP2 and VP3 which were not linked in early studies, but have recently been shown by others to be linked in type 1.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7685967     DOI： 10.1006/viro.1993.1044

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


  9 in total

1.  Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003.

Authors:  Masae Iwai; Hiromu Yoshida; Mayumi Obara; Eiji Horimoto; Kazuya Nakamura; Takenori Takizawa; Takeshi Kurata; Mineyuki Mizuguchi; Tohru Daikoku; Kimiyasu Shiraki
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

2.  Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure.

Authors:  T Herremans; J H Reimerink; T G Kimman; H G van Der Avoort; M P Koopmans
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

3.  Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.

Authors:  Jing Shaw; Jaume Jorba; Kun Zhao; Jane Iber; Qi Chen; Festus Adu; Adekunle Adeniji; David Bukbuk; Marycelin Baba; Elizabeth Henderson; Naomi Dybdahl-Sissoko; Sharla McDonald; William C Weldon; Nicksy Gumede; M Steven Oberste; Olen M Kew; Cara C Burns
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

4.  Diazadispiroalkane Derivatives Are New Viral Entry Inhibitors.

Authors:  Vadim Makarov; Elke Bogner; Rebekka Adfeldt; Janna Schmitz; Barbara Kropff; Marco Thomas; Natalia Monakhova; Julia E Hölper; Barbara G Klupp; Thomas C Mettenleiter
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

5.  Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative.

Authors:  Glynis Dunn; Dimitra Klapsa; Thomas Wilton; Lindsay Stone; Philip D Minor; Javier Martin
Journal:  PLoS Pathog       Date:  2015-08-27       Impact factor: 6.823

6.  Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?

Authors:  Kun Zhao; Jaume Jorba; Jing Shaw; Jane Iber; Qi Chen; Kelley Bullard; Olen M Kew; Cara C Burns
Journal:  Comput Struct Biotechnol J       Date:  2017-10-12       Impact factor: 7.271

7.  Antiretroviral Activity Of a Novel Pyrimidyl-Di(Diazaspiroalkane) Derivative.

Authors:  E A Novoselova; O B Riabova; I A Leneva; V G Nesterenko; R N Bolgarin; V A Makarov
Journal:  Acta Naturae       Date:  2017 Jan-Mar       Impact factor: 1.845

8.  Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.

Authors:  Mala Rakoto-Andrianarivelo; Sophie Guillot; Jane Iber; Jean Balanant; Bruno Blondel; Franck Riquet; Javier Martin; Olen Kew; Bakolalao Randriamanalina; Lalatiana Razafinimpiasa; Dominique Rousset; Francis Delpeyroux
Journal:  PLoS Pathog       Date:  2007-12       Impact factor: 6.823

9.  The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks.

Authors:  Andrew L Valesano; Mami Taniuchi; William J Fitzsimmons; Md Ohedul Islam; Tahmina Ahmed; Khalequ Zaman; Rashidul Haque; Wesley Wong; Michael Famulare; Adam S Lauring
Journal:  Cell Host Microbe       Date:  2020-11-18       Impact factor: 21.023
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.